The stock delivered higher returns than the benchmark Nifty Pharma over the past year
Kumiai Chemical's earnings revision highlights strong demand for pyroxasulfone, but concerns over generic competition and weak earnings growth keep analysts cautious on PI Industries
Krishna Kant & Ram Prasad Sahu delve into the earnings of the 10 biggest sectors in Q4FY26
PVC price swings, muted rural demand cloud near-term outlook
Analysts expect room rates to improve in the upcoming quarters as the impact of the West Asia crisis may normalise
Brokerages cut Bata India earnings estimates as weak margins and slow volume growth overshadow improving demand and revenue momentum
Strong domestic growth, an expanding specialty portfolio, acquisitions and a robust product pipeline are expected to support Zydus Lifesciences' performance in FY27
Strong demand, premium product mix and easing competition boosted paint makers' March-quarter performance, though the impact of price hikes on future volumes remains a key monitorable
Shares of Berger Paints India surged after strong Q4 earnings, with brokerages turning bullish on easing competition, double-digit growth prospects and improving margins in FY27
Bajaj Group's centenary is less a celebration than a pivot into healthcare, electric mobility and the AI age
In the centenary year marking the inception of Bajaj Group as a business house in Mumbai, Chairman Shekhar Bajaj speaks about the journey and the road ahead for Bajaj Electricals
Titan and Kalyan Jewellers posted strong Q4 revenue growth driven by jewellery demand, though rising bullion sales and gold prices weighed on margins
Analysts remain positive on Hero MotoCorp's demand outlook and launches, but warn that commodity inflation and price hikes could pressure margins
Strong EV demand and a robust order book power Q4 beat, but valuations and global slowdown concerns keep brokerages cautious
Value fashion segment expected to do better driven by same-store sales growth and store additions
Small caps outperform the Nifty 50 amid a risk-on rally, but rising valuations and macro risks raise concerns over sustainability
Brokerages remain positive on Max Healthcare despite recent weakness, expecting growth revival in FY27 led by expansion, better occupancy, improved mix and strong margins
Maruti Suzuki shares rose after a strong Q4 performance, with analysts positive on domestic demand outlook despite near-term pressure on margins from higher costs.
Africa push, category expansion and pricing support drive estimate upgrades
Sun Pharma's Organon deal lifts stock, but growth concerns and high debt at the acquired firm may cap upside despite synergy potential